Novel generations of influenza vaccines

  • Kemble G
  • Greenberg H
  • 40


    Mendeley users who have this article in their library.
  • 70


    Citations of this article.


Several strategies are being pursued to increase the quality and quantity of influenza vaccines that are used on an annual basis including increasing the immunogenicity of currently licensed inactivated vaccines, delivery of inactive vaccines directly to the nasal mucosa, the use of cell lines for virus production and the use of live, attenuated vaccines. In addition, modern molecular biological techniques are being used to create and evaluate new vaccine approaches. This report will briefly review these different strategies and outline some of the potential advantages and challenges associated with them. © 2003 Elsevier Science Ltd. All rights reserved.

Author-supplied keywords

  • Adjuvants
  • Immunogenicity
  • Influenza

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • George Kemble

  • Harry Greenberg

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free